Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting
Authors' conclusion
We found that there is a large variability in nearly all of those aspects and, in particular, in the characteristics of the comparator measurements. Furthermore, these characteristics as well as other crucial aspects of study design are often not reported in sufficient detail to allow an informed interpretation of study results.
Study context
- Population
- Clinical continuous glucose monitoring (CGM) performance evaluations published 2002–2022
- Outcome
- Variability in CGM performance study design
Methodological detailsRecommendations provided for reporting general study design, CGM system use, comparator measurement approach, testing procedures and data analysis/statistical performance evaluation
- Recommendations provided for reporting general study design, CGM system use, comparator measurement approach, testing procedures and data analysis/statistical performance evaluation
Main finding
As reported in the abstract
- Large variability in nearly all aspects of study design (subject population, comparator method, testing procedures, statistical accuracy evaluation), in particular in comparator measurement characteristics
- Comparator characteristics and other crucial design aspects often not reported in sufficient detail to allow informed interpretation of results
Original publication
Clinical Performance Evaluation of Continuous Glucose Monitoring Systems: A Scoping Review and Recommendations for Reporting. J Diabetes Sci Technol. Published 20 August 2023. doi:10. 1177/ 19322968231190941
Composed by AI from the published abstract and checked against it. How Briefs are made →